249 related articles for article (PubMed ID: 20456363)
1. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
Rosenberg PS; Zeidler C; Bolyard AA; Alter BP; Bonilla MA; Boxer LA; Dror Y; Kinsey S; Link DC; Newburger PE; Shimamura A; Welte K; Dale DC
Br J Haematol; 2010 Jul; 150(2):196-9. PubMed ID: 20456363
[TBL] [Abstract][Full Text] [Related]
2. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
[TBL] [Abstract][Full Text] [Related]
4. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
Freedman MH; Alter BP
Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
[TBL] [Abstract][Full Text] [Related]
5. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
6. Absence of mutations in the granulocyte colony-stimulating factor (G-CSF) receptor gene in patients with myelodysplastic syndrome/acute myeloblastic leukaemia occurring after treatment of aplastic anaemia with G-CSF.
Kudo K; Nagai H; Numata S; Ichihara M; Kinoshita T; Horibe K; Kato K; Matsuyama T; Kodera Y; Kojima S
Br J Haematol; 2000 Nov; 111(2):656-8. PubMed ID: 11122117
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.
Rosenberg PS; Alter BP; Link DC; Stein S; Rodger E; Bolyard AA; Aprikyan AA; Bonilla MA; Dror Y; Kannourakis G; Newburger PE; Boxer LA; Dale DC
Br J Haematol; 2008 Jan; 140(2):210-3. PubMed ID: 18028488
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
[TBL] [Abstract][Full Text] [Related]
9. Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.
Salehi T; Fazlollahi MR; Maddah M; Nayebpour M; Tabatabaei Yazdi M; Alizadeh Z; Eshghi P; Chavoshzadeh Z; Movahedi M; Hamidieh AA; Cheraghi T; Pourpak Z; Moin M
Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):51-6. PubMed ID: 22427476
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of myeloid growth factor treatment.
Lyman GH; Dale DC
J Natl Compr Canc Netw; 2011 Aug; 9(8):945-52. PubMed ID: 21900223
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor.
Dale DC; Bolyard AA; Shannon JA; Connelly JA; Link DC; Bonilla MA; Newburger PE
Blood Adv; 2022 Jul; 6(13):3861-3869. PubMed ID: 35476051
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
[TBL] [Abstract][Full Text] [Related]
13. [Chronic neutropenia].
Palmblad J; Elinder G
Nord Med; 1996 Nov; 111(9):304-7. PubMed ID: 8966113
[TBL] [Abstract][Full Text] [Related]
14. [Gene Mutation and Acute Leukemia Transformation of Severe Congenital Neutropenia- Review].
Chi ZH; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1580-1584. PubMed ID: 29070147
[TBL] [Abstract][Full Text] [Related]
15. G-CSF and its receptor in myeloid malignancy.
Beekman R; Touw IP
Blood; 2010 Jun; 115(25):5131-6. PubMed ID: 20237318
[TBL] [Abstract][Full Text] [Related]
16. Game of clones: the genomic evolution of severe congenital neutropenia.
Touw IP
Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
[TBL] [Abstract][Full Text] [Related]
17. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
Kalra R; Dale D; Freedman M; Bonilla MA; Weinblatt M; Ganser A; Bowman P; Abish S; Priest J; Oseas RS; Olson K; Paderanga D; Shannon K
Blood; 1995 Dec; 86(12):4579-86. PubMed ID: 8541548
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of leukemic transformation in congenital neutropenia.
Link DC
Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration.
Imashuku S; Hibi S; Kataoka-Morimoto Y; Yoshihara T; Ikushima S; Morioka Y; Todo S
Br J Haematol; 1995 Jan; 89(1):188-90. PubMed ID: 7530477
[TBL] [Abstract][Full Text] [Related]
20. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
